Transcatheter deep venous arterialization was tied to high rates of limb salvage and wound healing in patients with “no ...

Findings from the AltaValve Early Feasibility Study suggest that patients with a leaky mitral valve have sustained clinical ...

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...

Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its All Patient ...

In a large randomized trial, treating patients with acute hypoxemic respiratory failure with high-flow oxygen didn't improve survival compared with standard oxygen. However, high-flow oxygen did ...

Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory ...

Disclosure forms provided by the author are available with the full text of this editorial at NEJM.org. Ary Serpa Neto, M.D., Ph.D. Australian and New Zealand Intensive Care Research Centre, School of ...

Clearway Energy has growth visibility into the 2030s. Chevron has increased its dividend for 39 years in a row. Kinder Morgan has a large and growing backlog of expansion projects. The energy sector ...

AI-powered dictation startup Wispr Flow has launched its Android app today. The company released its app for Mac and Windows first, then launched on iOS in June 2025. On iOS, users could use Wispr ...

Google announced changes to Android app sideloading last year that would require developer verification as a safety measure, but the company somewhat backtracked with ...

Google says Android is getting a “high-friction” sideloading flow. The company insists it’s about user awareness, not blocking installs. The big question is whether this added friction will stay ...

Verizon's dividend yield currently stands at nearly 7%. The underlying business is growing, but at a very slow rate. The company's business throws off significant free cash flow. For investors looking ...